{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:59:27Z","timestamp":1767650367144,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T00:00:00Z","timestamp":1487635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T00:00:00Z","timestamp":1487635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["N02-CP-10128","N02-CP-11004","N02-CP-11161"],"award-info":[{"award-number":["N02-CP-10128","N02-CP-11004","N02-CP-11161"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s10552-017-0857-3","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T15:54:38Z","timestamp":1487692478000},"page":"289-297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Antihypertensive medication use and risk of renal cell carcinoma"],"prefix":"10.1007","volume":"28","author":[{"given":"Joanne S.","family":"Colt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan N.","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kendra","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wong-Ho","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry I.","family":"Graubard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faith","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Ruterbusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Berndt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark P.","family":"Purdue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,21]]},"reference":[{"key":"857_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. Ca Cancer J Clin 63:11\u201330.","journal-title":"Ca Cancer J Clin"},{"key":"857_CR2","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1002\/ijc.27934","volume":"132","author":"MP Purdue","year":"2013","unstructured":"Purdue MP, Moore LE, Merino MJ et al (2013) An investigation of risk factors for renal cell carcinoma by histologic subtype in two case\u2013control studies. Int J Cancer 132:2640\u20132647","journal-title":"Int J Cancer"},{"key":"857_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nrurol.2010.46","volume":"7","author":"WH Chow","year":"2010","unstructured":"Chow WH, Dong LM, Devesa SS (2010) Epidemiology and risk factors for kidney cancer. Nat Rev Urol 7:245\u2013257","journal-title":"Nat Rev Urol"},{"key":"857_CR4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/EDE.0b013e3182300720","volume":"22","author":"JS Colt","year":"2011","unstructured":"Colt JS, Schwartz K, Graubard BI et al (2011) Hypertension and risk of renal cell carcinoma among white and black Americans. Epidemiology 22:797\u2013804","journal-title":"Epidemiology"},{"key":"857_CR5","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/j.juro.2011.02.001","volume":"185","author":"H Liu","year":"2011","unstructured":"Liu H, Hemminki K, Sundquist J (2011) Renal cell carcinoma as first and second primary cancer: etiological clues from the swedish family-cancer database. J Urology 185:2045\u20132049","journal-title":"J Urology"},{"key":"857_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1467-9876.2010.00731.x","volume":"60","author":"L Y","year":"2011","unstructured":"Y L, BI G, R D (2011) Weighting methods for population-based case\u2013control studies with complex sampling. J R Stat Soc Serv C Appl Stat 60:165\u2013185","journal-title":"J R Stat Soc Serv C Appl Stat"},{"key":"857_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1177\/096228029600500305","volume":"5","author":"KF Rust","year":"1996","unstructured":"Rust KF, Rao JN. (1996) Variance estimation for complex surveys using replication techniques. Stat Methods Med Res 5:283\u2013310.","journal-title":"Stat Methods Med Res"},{"key":"857_CR8","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/BF00052431","volume":"4","author":"WD Finkle","year":"1993","unstructured":"Finkle WD, McLaughlin JK, Rasgon SA, Yeoh HH, Low JE (1993) Increased risk of renal cell cancer among women using diuretics in the United States. Cancer Causes Control 4:555\u2013558","journal-title":"Cancer Causes Control"},{"key":"857_CR9","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s10552-005-0349-8","volume":"16","author":"KT Flaherty","year":"2005","unstructured":"Flaherty KT, Fuchs CS, Colditz GA et al (2005) A prospective study of body mass index, hypertension, and smoking and the risk of renal cell carcinoma (United States). Cancer Causes Control 16:1099\u20131106","journal-title":"Cancer Causes Control"},{"key":"857_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/BF01804982","volume":"5","author":"RA Hiatt","year":"1994","unstructured":"Hiatt RA, Tolan K, Quesenberry CP Jr (1994) Renal cell carcinoma and thiazide use: a historical, case\u2013control study (California, USA). Cancer Causes Control 5:319\u2013325","journal-title":"Cancer Causes Control"},{"key":"857_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF00053150","volume":"4","author":"N Kreiger","year":"1993","unstructured":"Kreiger N, Marrett LD, Dodds L, Hilditch S, Darlington GA (1993) Risk factors for renal cell carcinoma: results of a population-based case\u2013control study. Cancer Causes Control 4:101\u2013110","journal-title":"Cancer Causes Control"},{"key":"857_CR12","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/ije\/23.5.923","volume":"23","author":"A Mellemgaard","year":"1994","unstructured":"Mellemgaard A, Niwa S, Mehl ES, Engholm G, McLaughlin JK, Olsen JH (1994) Risk factors for renal cell carcinoma in Denmark: role of medication and medical history. Int J Epidemiol 23:923\u2013930","journal-title":"Int J Epidemiol"},{"key":"857_CR13","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/aje\/kwm170","volume":"166","author":"VW Setiawan","year":"2007","unstructured":"Setiawan VW, Stram DO, Nomura AM, Kolonel LN, Henderson BE. (2007) Risk factors for renal cell cancer: the multiethnic cohort. Am J Epidemiol 166:932\u2013940.","journal-title":"Am J Epidemiol"},{"key":"857_CR14","first-page":"351","volume":"77","author":"MC Yu","year":"1986","unstructured":"Yu MC, Mack TM, Hanisch R, Cicioni C, Henderson BE (1986) Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma. J Natl Cancer Inst 77:351\u2013356","journal-title":"J Natl Cancer Inst"},{"key":"857_CR15","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/oxfordjournals.aje.a009157","volume":"145","author":"CW Heath Jr","year":"1997","unstructured":"Heath CW Jr, Lally CA, Calle EE, McLaughlin JK, Thun MJ (1997) Hypertension, diuretics, and antihypertensive medications as possible risk factors for renal cell cancer. Am J Epidemiol 145:607\u2013613","journal-title":"Am J Epidemiol"},{"key":"857_CR16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/BF00146885","volume":"3","author":"M McCredie","year":"1992","unstructured":"McCredie M, Stewart JH (1992) Risk factors for kidney cancer in New South Wales, Australia. II. Urologic disease, hypertension, obesity, and hormonal factors. Cancer Causes Control 3:323\u2013331","journal-title":"Cancer Causes Control"},{"key":"857_CR17","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/jnci\/80.5.378","volume":"80","author":"JK McLaughlin","year":"1988","unstructured":"McLaughlin JK, Blot WJ, Fraumeni JF Jr (1988) Diuretics and renal cell cancer. J Natl Cancer Inst 80:378","journal-title":"J Natl Cancer Inst"},{"key":"857_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/00001648-199701000-00005","volume":"8","author":"RJ Prineas","year":"1997","unstructured":"Prineas RJ, Folsom AR, Zhang ZM, Sellers TA, Potter J (1997) Nutrition and other risk factors for renal cell carcinoma in postmenopausal women. Epidemiology 8:31\u201336","journal-title":"Epidemiology"},{"key":"857_CR19","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/oxfordjournals.aje.a009848","volume":"149","author":"JA Shapiro","year":"1999","unstructured":"Shapiro JA, Williams MA, Weiss NS, Stergachis A, LaCroix AZ, Barlow WE (1999) Hypertension, antihypertensive medication use, and risk of renal cell carcinoma. Am J Epidemiol 149:521\u2013530","journal-title":"Am J Epidemiol"},{"key":"857_CR20","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/ijc.2910630212","volume":"63","author":"JK McLaughlin","year":"1995","unstructured":"McLaughlin JK, Chow WH, Mandel JS et al (1995) International renal-cell cancer study. VIII. Role of diuretics, other anti-hypertensive medications and hypertension. Int J Cancer 63:216\u2013221","journal-title":"Int J Cancer"},{"key":"857_CR21","first-page":"327","volume":"4","author":"WH Chow","year":"1995","unstructured":"Chow WH, McLaughlin JK, Mandel JS, Wacholder S, Niwa S, Fraumeni JF Jr (1995) Risk of renal cell cancer in relation to diuretics, antihypertensive drugs, and hypertension. Cancer Epidemiol Biomark Prev 4:327\u2013331","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"857_CR22","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/oxfordjournals.aje.a117328","volume":"140","author":"S Weinmann","year":"1994","unstructured":"Weinmann S, Glass AG, Weiss NS, Psaty BM, Siscovick DS, White E (1994) Use of diuretics and other antihypertensive medications in relation to the risk of renal cell cancer. Am J Epidemiol 140:792\u2013804","journal-title":"Am J Epidemiol"},{"key":"857_CR23","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/bjc.1998.248","volume":"77","author":"JM Yuan","year":"1998","unstructured":"Yuan JM, Castelao JE, Gago-Dominguez M, Ross RK, Yu MC (1998) Hypertension, obesity and their medications in relation to renal cell carcinoma. Br J Cancer 77:1508\u20131513","journal-title":"Br J Cancer"},{"key":"857_CR24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0140-6736(96)04277-8","volume":"348","author":"M Pahor","year":"1996","unstructured":"Pahor M, Guralnik JM, Ferrucci L et al (1996) Calcium-channel blockade and incidence of cancer in aged populations. Lancet 348:493\u2013497","journal-title":"Lancet"},{"key":"857_CR25","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/0895-7061(96)00186-0","volume":"9","author":"M Pahor","year":"1996","unstructured":"Pahor M, Guralnik JM, Salive ME, Corti MC, Carbonin P, Havlik RJ. (1996) Do calcium channel blockers increase the risk of cancer? Am J Hypertens 9:695\u2013699.","journal-title":"Am J Hypertens"},{"key":"857_CR26","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0140-6736(97)80084-0","volume":"349","author":"H Jick","year":"1997","unstructured":"Jick H, Jick S, Derby LE, Vasilakis C, Myers MW, Meier CR (1997) Calcium-channel blockers and risk of cancer. Lancet 349:525\u2013528","journal-title":"Lancet"},{"key":"857_CR27","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1161\/01.HYP.29.5.1091","volume":"29","author":"JH Olsen","year":"1997","unstructured":"Olsen JH, Sorensen HT, Friis S et al (1997) Cancer risk in users of calcium channel blockers. Hypertension 29:1091\u20131094","journal-title":"Hypertension"},{"key":"857_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/00004872-199816010-00017","volume":"16","author":"DJ Hole","year":"1998","unstructured":"Hole DJ, Gillis CR, McCallum IR et al (1998) Cancer risk of hypertensive patients taking calcium antagonists. J Hypertens 16:119\u2013124","journal-title":"J Hypertens"},{"key":"857_CR29","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1001\/jama.279.13.1000","volume":"279","author":"L Rosenberg","year":"1998","unstructured":"Rosenberg L, Rao RS, Palmer JR et al (1998) Calcium channel blockers and the risk of cancer. JAMA 279:1000\u20131004","journal-title":"JAMA"},{"key":"857_CR30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/1097-0142(20000701)89:1<165::AID-CNCR21>3.0.CO;2-G","volume":"89","author":"HT Sorensen","year":"2000","unstructured":"Sorensen HT, Olsen JH, Mellemkjaer L et al (2000) Cancer risk and mortality in users of calcium channel blockers. A cohort study. Cancer 89:165\u2013170","journal-title":"Cancer"},{"key":"857_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/sj.jhh.1001000","volume":"14","author":"M Stahl","year":"2000","unstructured":"Stahl M, Bulpitt CJ, Palmer AJ, Beevers DG, Coles EC, Webster J (2000) Calcium channel blockers, ACE inhibitors, and the risk of cancer in hypertensive patients: a report from the Department of Health Hypertension Care Computing Project (DHCCP). J Hum Hypertens 14:299\u2013304","journal-title":"J Hum Hypertens"},{"key":"857_CR32","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"ALLHAT","year":"2002","unstructured":"ALLHAT. (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 288:2981\u201397","journal-title":"JAMA"},{"key":"857_CR33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11906-002-0007-4","volume":"4","author":"E Grossman","year":"2002","unstructured":"Grossman E, Messerli FH, Goldbourt U. (2002) Carcinogenicity of antihypertensive therapy. Curr Hypertens Rep 4: 195\u2013201.","journal-title":"Curr Hypertens Rep"},{"key":"857_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1470-2045(10)70260-6","volume":"12","author":"S Bangalore","year":"2011","unstructured":"Bangalore S, Kumar S, Kjeldsen SE et al (2011) Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. Lancet Oncol 12:65\u201382","journal-title":"Lancet Oncol"},{"key":"857_CR35","first-page":"217","volume":"1","author":"AK Gupta","year":"2010","unstructured":"Gupta AK. (2010) Racial differences in response to antihypertensive therapy: does one size fits all? Int J Prev Med 1:217\u20139.","journal-title":"Int J Prev Med"},{"key":"857_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0041-008X(77)90124-7","volume":"40","author":"B Gold","year":"1977","unstructured":"Gold B, Mirvish SS. (1977) N-Nitroso derivatives of hydrochlorothiazide, niridazole, and tolbutamide. Toxicol Appl Pharmacol 40:131\u20136.","journal-title":"Toxicol Appl Pharmacol"},{"key":"857_CR37","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S0002-9149(99)00021-1","volume":"83","author":"E Grossman","year":"1999","unstructured":"Grossman E, Messerli FH, Goldbourt U (1999) Does diuretic therapy increase the risk of renal cell carcinoma? Am J Cardiol 83:1090\u20133.","journal-title":"Am J Cardiol"},{"key":"857_CR38","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1097\/01.hjh.0000186023.74245.48","volume":"23","author":"LJ Schouten","year":"2005","unstructured":"Schouten LJ, van Dijk BA, Oosterwijk E et al (2005) Hypertension, antihypertensives and mutations in the Von Hippel-Lindau gene in renal cell carcinoma: results from the Netherlands Cohort Study. J Hypertens 23:1997\u20132004","journal-title":"J Hypertens"},{"key":"857_CR39","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/074823378700300313","volume":"3","author":"W Lijinsky","year":"1987","unstructured":"Lijinsky W, Reuber MD (1987) Pathologic effects of chronic administration of hydrochlorothiazide, with and without sodium nitrite, to F344 rats. Toxicol Ind Health Lond 3:413\u2013422","journal-title":"Toxicol Ind Health Lond"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-017-0857-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-017-0857-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-017-0857-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T14:25:37Z","timestamp":1658672737000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-017-0857-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,21]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["857"],"URL":"https:\/\/doi.org\/10.1007\/s10552-017-0857-3","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"type":"print","value":"0957-5243"},{"type":"electronic","value":"1573-7225"}],"subject":[],"published":{"date-parts":[[2017,2,21]]},"assertion":[{"value":"12 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}